2020
Genetic Architecture of Abdominal Aortic Aneurysm in the Million Veteran Program
Klarin D, Verma S, Judy R, Dikilitas O, Wolford B, Paranjpe I, Levin M, Pan C, Tcheandjieu C, Spin J, Lynch J, Assimes T, Åldstedt Nyrønning L, Mattsson E, Edwards T, Denny J, Larson E, Lee M, Carrell D, Zhang Y, Jarvik G, Gharavi A, Harley J, Mentch F, Pacheco J, Hakonarson H, Skogholt A, Thomas L, Gabrielsen M, Hveem K, Nielsen J, Zhou W, Fritsche L, Huang J, Natarajan P, Sun Y, DuVall S, Rader D, Cho K, Chang K, Wilson P, O’Donnell C, Kathiresan S, Scali S, Berceli S, Willer C, Jones G, Bown M, Nadkarni G, Kullo I, Ritchie M, Damrauer S, Tsao P, Gaziano J, Ramoni R, Beckham J, Breeling J, Chang K, Huang G, Muralidhar S, O’Donnell C, Casas Romero J, Tsao P, Muralidhar S, Moser J, Whitbourne S, Brewer J, Concato J, Warren S, Argyres D, Tsao P, Gaziano J, Stephens B, Brophy M, Humphries D, Do N, Shayan S, Nguyen X, O’Donnell C, Pyarajan S, Tsao P, Cho K, Pyarajan S, Hauser E, Sun Y, Zhao H, Wilson P, McArdle R, Dellitalia L, Harley J, Zablocki C, Whittle J, Beckham J, Wells J, Gutierrez S, Gibson G, Kaminsky L, Villareal G, Kinlay S, Xu J, Hamner M, Haddock K, Bhushan S, Iruvanti P, Godschalk M, Ballas Z, Buford M, Mastorides S, Klein J, Ratcliffe N, Florez H, Swann A, Murdoch M, Sriram P, Yeh S, Washburn R, Jhala D, Aguayo S, Cohen D, Sharma S, Callaghan J, Oursler K, Whooley M, Ahuja S, Gutierrez A, Schifman R, Greco J, Rauchman M, Servatius R, Oehlert M, Wallbom A, Fernando R, Morgan T, Stapley T, Sherman S, Anderson G, Tsao P, Sonel E, Boyko E, Meyer L, Gupta S, Fayad J, Hung A, Lichy J, Hurley R, Robey B, Striker R. Genetic Architecture of Abdominal Aortic Aneurysm in the Million Veteran Program. Circulation 2020, 142: 1633-1646. PMID: 32981348, PMCID: PMC7580856, DOI: 10.1161/circulationaha.120.047544.Peer-Reviewed Original ResearchConceptsAbdominal aortic aneurysmBlood pressurePolygenic risk scoresAortic aneurysmFamily historyDiastolic blood pressureSystolic blood pressureGenome-wide polygenic risk scoreRisk variantsSmoking risk factorsMendelian randomization analysisAAA prevalenceCardiovascular mortalityRisk factorsAAA developmentArterial bedCurrent guidelinesVascular territoriesLower extremitiesMillion Veteran ProgramRisk scoreTherapeutic implicationsCurrent screeningImportant causeAAA risk
2010
One-year costs associated with cardiovascular disease in Canada: Insights from the REduction of Atherothrombosis for Continued Health (REACH) registry
Smolderen KG, Bell A, Lei Y, Cohen EA, Steg PG, Bhatt DL, Mahoney EM, investigators O. One-year costs associated with cardiovascular disease in Canada: Insights from the REduction of Atherothrombosis for Continued Health (REACH) registry. Canadian Journal Of Cardiology 2010, 26: e297-e305. PMID: 20931098, PMCID: PMC2954538, DOI: 10.1016/s0828-282x(10)70437-2.Peer-Reviewed Original ResearchConceptsPeripheral arterial diseaseContinued Health (REACH) RegistryReduction of AtherothrombosisCardiovascular risk factorsCoronary artery diseaseArterial bedMedication useHospitalization costsAtherothrombotic diseaseArtery diseaseMedication costsCerebrovascular diseaseHealth registriesRisk factorsEconomic burdenMore cardiovascular risk factorsAnnual hospitalization costsCardiovascular-related hospitalizationsMean hospitalization costOne-year followOne-year costsCardiovascular eventsPolyvascular diseaseAnnual hospitalizationsClinical factors
2002
Phosphorylation of eNOS initiates excessive NO production in early phases of portal hypertension
Iwakiri Y, Tsai MH, McCabe TJ, Gratton JP, Fulton D, Groszmann RJ, Sessa WC. Phosphorylation of eNOS initiates excessive NO production in early phases of portal hypertension. AJP Heart And Circulatory Physiology 2002, 282: h2084-h2090. PMID: 12003815, DOI: 10.1152/ajpheart.00675.2001.Peer-Reviewed Original ResearchMeSH KeywordsAdrenergic alpha-1 Receptor AgonistsAndrostadienesAnimalsEnzyme InhibitorsHypertension, PortalLigationMaleMesenteric Artery, SuperiorMethoxamineNitric OxideNitric Oxide SynthaseNitric Oxide Synthase Type IIIomega-N-MethylargininePhosphorylationPortal VeinProtein Serine-Threonine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-aktRatsRats, Sprague-DawleyVasoconstrictor AgentsWortmanninConceptsEndothelial nitric oxide synthasePortal vein ligationPhosphorylation of eNOSMesenteric arterial bedPortal hypertensionPVL groupArterial bedNO productionMale Sprague-Dawley ratsEarly portal hypertensionMonomethyl-L-arginineNitric oxide synthaseSprague-Dawley ratsExcessive NO productionG protein-coupled receptorsVivo perfusion studiesPVL ratsProtein-coupled receptorsPerfusion pressureSham groupVein ligationENOS expressionOxide synthaseReduced responsivenessKinase/Akt pathway
1999
Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility
Wiest R, Das S, Cadelina G, Garcia-Tsao G, Milstien S, Groszmann R. Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility. Journal Of Clinical Investigation 1999, 104: 1223-1233. PMID: 10545521, PMCID: PMC409820, DOI: 10.1172/jci7458.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsBacterial TranslocationDose-Response Relationship, DrugLiver Cirrhosis, ExperimentalLymph NodesMaleMesenteric ArteriesMethoxamineNitric OxideNitric Oxide SynthasePerfusionPressureProtein IsoformsRatsRats, Sprague-DawleyStress, MechanicalTumor Necrosis Factor-alphaVasoconstrictionVasoconstrictor AgentsConceptsMesenteric lymph nodesEndothelial NO synthaseTNF-alpha productionAscitic cirrhotic ratsBacterial translocationCirrhotic ratsMesenteric vasculatureNitric oxidePresence of BTSuperior mesenteric arterial bedMesenteric arterial bedNitro-L-arginineTNF-alpha synthesisVascular hyporesponsivenessArterial vasodilationLiver cirrhosisLymph nodesVascular contractilityVascular responsesTNF-alphaArterial bedNO inhibitorNOS activityNO overproductionNO synthase
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply